The company added that AMAR's approval will allow people with diabetes in Israel to soon join the initial Dario users in the UK, Italy and New Zealand where the initial market launch of the iOS version of Dario began in late March 2014.
Dario is a cloud-based, diabetes management solution that includes novel software applications combined with the stylish, 'all-in-one', pocket-sized, Dario Smart Meter, which interfaces with a user's mobile device to form the overall Dario Diabetes Management Solution, allowing diabetics to monitor their blood sugars and other activities and gain insights into managing their disease using their mobile devices, said the company.
In addition, the Dario App has already been launched in Israel and is available on the App store for iPhones and on Google Play for Android smartphones, concluded the company.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia